Propanc Biopharma, Inc. Debt Conversion, Converted Instrument, Amount
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2023-05-15
- Propanc Biopharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2021-03-31 was $303.73K, a 49.71% decline year-over-year.
- Propanc Biopharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2020-12-31 was $112.98K.
- Propanc Biopharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2020-09-30 was $391.94K.
- Propanc Biopharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2020-06-30 was -$922.25K.
- Propanc Biopharma, Inc. debt conversion, converted instrument, amount for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Propanc Biopharma, Inc. debt conversion, converted instrument, amount for fiscal 2015 was $152.28K.
- Propanc Biopharma, Inc. debt conversion, converted instrument, amount for fiscal 2014 was $0.00.
| Period end | Debt Conversion, Converted Instrument, Amount 0 month | Debt Conversion, Converted Instrument, Amount 1 month | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|---|---|
| 2021-03-31 | $303.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $416.71K derived: sum of 2 quarters · filed 2021-05-14 | $808.65K 10-Q · filed 2021-05-14 | -$113.61K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2020-12-31 | $112.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-12 | $504.92K 10-Q · filed 2021-02-12 | -$417.33K derived: sum of 3 quarters · filed 2023-05-15 | $186.65K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2020-09-30 | $391.94K 10-Q · filed 2020-11-16 | -$530.32K derived: sum of 2 quarters · filed 2023-05-15 | $73.67K derived: sum of 3 quarters · filed 2023-05-15 | |||
| 2020-06-30 | -$922.25K derived: 10-Q 12 month − 10-Q 9 month · filed 2023-05-15 | -$318.27K derived: sum of 2 quarters · filed 2023-05-15 | $500.00 10-Q · filed 2023-05-15 | |||
| 2020-03-31 | $603.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $922.75K 10-Q · filed 2020-05-15 | ||||
| 2019-12-31 | $318.77K 10-Q · filed 2020-02-14 | |||||
| 2019-03-31 | $583.33K 10-Q · filed 2019-05-15 | $1.68M derived: sum of 2 quarters · filed 2019-05-15 | $3.09M derived: sum of 3 quarters · filed 2019-05-15 | |||
| 2018-12-31 | $1.10M 10-Q · filed 2019-05-15 | $2.51M derived: sum of 2 quarters · filed 2019-05-15 | ||||
| 2018-09-30 | $1.41M 10-Q · filed 2019-05-15 | |||||
| 2017-12-31 | $237.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-09 | $380.09K 10-Q · filed 2018-02-09 | ||||
| 2017-09-30 | $142.50K 10-Q · filed 2017-11-09 | |||||
| 2017-03-02 | $50.00K 10-K · filed 2018-09-17 | |||||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $0.00 10-K · filed 2016-09-28 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-16 | |||||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $152.28K 10-K · filed 2016-09-28 | ||||
| 2015-03-31 | $152.28K 10-Q · filed 2016-05-16 | |||||
| 2014-07-31 | $139.68K 10-Q · filed 2015-02-17 | |||||
| 2014-07-02 | $139.68K 10-K · filed 2015-09-30 | $139.68K 10-K · filed 2016-09-28 | ||||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-30 | $0.00 10-K · filed 2015-09-30 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-15 |